Quick Takeaways
- Michael J. Catelani filed SCHEDULE 13D/A for Anixa Biosciences, Inc. Common Stock (ANIX).
- Disclosed ownership: 7%.
- Date of event: 05 Jan 2026.
Michael J. Catelani - 05 Jan 2026 SCHEDULE 13D/A Report for Anixa Biosciences, Inc. Common Stock (ANIX)
- Filing Manager
- Michael J. Catelani
- Reporting Manager
- Michael Catelani
- Security
- Anixa Biosciences, Inc. Common Stock
- Symbol
- ANIX
- Shares outstanding
- 35,258,614 shares
- Disclosed Ownership
- 2,468,103 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13D/A
- Filing time
- 06 Jan 2026, 19:48:10 UTC
- Date of event
- 05 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael J. Catelani disclosed 7% ownership in Anixa Biosciences, Inc. Common Stock (ANIX) on 05 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Jan 2026, 19:48.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Michael Catelani | 7% | 2,468,103 | 2,468,103 | 0 | /s/ Michael Catelani | Michael Catelani | 0001689394 |